×

Novavax Announces Publication of Phase 1 Data for COVID-19 Vaccine Candidate in The New England Journal of Medicine

Published Sep 02 2020 at 4:09 AM GMT
Key
Points
  • 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc.
  • (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the publication.




Trending

Stats

  • Published Sep 2, 2020 4:09 AM GMT